Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly ...

No one knows how they will react to the news they have a life-threatening illness. But when a doctor told me, "Your prostate is covered in cancer" my reaction was to stand up, turn around and walk out ...

Explore integrative therapies for metastatic prostate cancer, including nutrition, acupuncture, supplements, exercise, and ...

A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to test the ability of grape seed extract to slow ...

Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...

A new ASTRO clinical guideline recommends moderately shortened radiation schedules for all risk groups of localized prostate cancer and establishes five-session SBRT as a standard option for many ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

A partitioned-survival lifetime model (2025 USD) compared ADT alone with seven intensification strategies across PFS, post-progression, and death, using published survival curves and literature-based ...

Newswise — BOSTON, September 28, 2026 — Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in ...